Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis

Abstract Background Resistin is a small protein that has pro-inflammatory and atherogenic effects. This study aimed to evaluate the level of serum resistin as a marker of subclinical atherosclerosis in multiple sclerosis (MS) sufferers. 114 MS sufferers and 114 age, sex and body mass index matched c...

Full description

Bibliographic Details
Main Authors: Rania S. Nageeb, Heba F. Tantawy, Amal Fawzy, Marwa Abdel-monem Ateya
Format: Article
Language:English
Published: SpringerOpen 2023-10-01
Series:The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:
Online Access:https://doi.org/10.1186/s41983-023-00733-4
_version_ 1797577389124878336
author Rania S. Nageeb
Heba F. Tantawy
Amal Fawzy
Marwa Abdel-monem Ateya
author_facet Rania S. Nageeb
Heba F. Tantawy
Amal Fawzy
Marwa Abdel-monem Ateya
author_sort Rania S. Nageeb
collection DOAJ
description Abstract Background Resistin is a small protein that has pro-inflammatory and atherogenic effects. This study aimed to evaluate the level of serum resistin as a marker of subclinical atherosclerosis in multiple sclerosis (MS) sufferers. 114 MS sufferers and 114 age, sex and body mass index matched controls were enrolled in this study, subjected to detailed history taking, general, neurological examination, assessment of anthropometric measurements, serum resistin level, and carotid duplex to asses subclinical atherosclerosis. Results MS sufferers showed a higher cholesterol, and triglycerides levels as compared to controls. Progressive MS sufferers (SPMS, and PPMS) showed a higher cholesterol level as compared to RRMS sufferers. SPMS sufferers showed a higher cholesterol level as compared to PPMS sufferers. RRMS sufferers showed a higher triglycerides level as compared to progressive MS sufferers. Sufferers had significantly higher mean levels of resistin and right carotid intimal medial thickness (CIMT) as compared to controls. There was a significant positive correlation in MS sufferers between serum resistin and the following parameters: age, and disease duration, body mass index, triglycerides, cholesterol and low-density lipoprotein. There were significant positive correlations between carotid intimal medial thickness and body mass index, disease duration, age, expanded disability status scale, levels of triglycerides, low-density lipoprotein, and cholesterol. The risk factors of subclinical atherosclerosis in MS sufferers were higher mean levels of resistin, triglycerides, low-density lipoprotein, cholesterol, and disease duration. Subclinical atherosclerosis in MS sufferers was significantly associated with higher mean levels of resistin, and triglycerides. Conclusions Higher mean levels of resistin might reflect the predisposition to subclinical atherosclerosis in MS sufferers.
first_indexed 2024-03-10T22:07:33Z
format Article
id doaj.art-9d9b29a5f8f64bf4a5fe68738ed18ac2
institution Directory Open Access Journal
issn 1687-8329
language English
last_indexed 2024-03-10T22:07:33Z
publishDate 2023-10-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
spelling doaj.art-9d9b29a5f8f64bf4a5fe68738ed18ac22023-11-19T12:44:49ZengSpringerOpenThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery1687-83292023-10-015911810.1186/s41983-023-00733-4Relation of serum resistin to subclinical atherosclerosis in multiple sclerosisRania S. Nageeb0Heba F. Tantawy1Amal Fawzy2Marwa Abdel-monem Ateya3Faculty of Medicine, Zagazig UniversityFaculty of Medicine, Zagazig UniversityFaculty of Medicine, Zagazig UniversityFaculty of Medicine, Zagazig UniversityAbstract Background Resistin is a small protein that has pro-inflammatory and atherogenic effects. This study aimed to evaluate the level of serum resistin as a marker of subclinical atherosclerosis in multiple sclerosis (MS) sufferers. 114 MS sufferers and 114 age, sex and body mass index matched controls were enrolled in this study, subjected to detailed history taking, general, neurological examination, assessment of anthropometric measurements, serum resistin level, and carotid duplex to asses subclinical atherosclerosis. Results MS sufferers showed a higher cholesterol, and triglycerides levels as compared to controls. Progressive MS sufferers (SPMS, and PPMS) showed a higher cholesterol level as compared to RRMS sufferers. SPMS sufferers showed a higher cholesterol level as compared to PPMS sufferers. RRMS sufferers showed a higher triglycerides level as compared to progressive MS sufferers. Sufferers had significantly higher mean levels of resistin and right carotid intimal medial thickness (CIMT) as compared to controls. There was a significant positive correlation in MS sufferers between serum resistin and the following parameters: age, and disease duration, body mass index, triglycerides, cholesterol and low-density lipoprotein. There were significant positive correlations between carotid intimal medial thickness and body mass index, disease duration, age, expanded disability status scale, levels of triglycerides, low-density lipoprotein, and cholesterol. The risk factors of subclinical atherosclerosis in MS sufferers were higher mean levels of resistin, triglycerides, low-density lipoprotein, cholesterol, and disease duration. Subclinical atherosclerosis in MS sufferers was significantly associated with higher mean levels of resistin, and triglycerides. Conclusions Higher mean levels of resistin might reflect the predisposition to subclinical atherosclerosis in MS sufferers.https://doi.org/10.1186/s41983-023-00733-4Multiple sclerosisResistinAtherosclerosisCarotid intimal–medial thicknessCarotid duplex and lipid profile
spellingShingle Rania S. Nageeb
Heba F. Tantawy
Amal Fawzy
Marwa Abdel-monem Ateya
Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Multiple sclerosis
Resistin
Atherosclerosis
Carotid intimal–medial thickness
Carotid duplex and lipid profile
title Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis
title_full Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis
title_fullStr Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis
title_full_unstemmed Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis
title_short Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis
title_sort relation of serum resistin to subclinical atherosclerosis in multiple sclerosis
topic Multiple sclerosis
Resistin
Atherosclerosis
Carotid intimal–medial thickness
Carotid duplex and lipid profile
url https://doi.org/10.1186/s41983-023-00733-4
work_keys_str_mv AT raniasnageeb relationofserumresistintosubclinicalatherosclerosisinmultiplesclerosis
AT hebaftantawy relationofserumresistintosubclinicalatherosclerosisinmultiplesclerosis
AT amalfawzy relationofserumresistintosubclinicalatherosclerosisinmultiplesclerosis
AT marwaabdelmonemateya relationofserumresistintosubclinicalatherosclerosisinmultiplesclerosis